Step by Step






Credit Hours: CME 1.25

Target Audience:

This activity is directed to physicians who take care of hospitalized children, medical students, nurse practitioners, and physician assistants working in the emergency room, intensive care unit, or hospital wards.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Review the literature on the Hydroxychloroquine’s use in COVID-19 infection.
  • Review the literature on Angiotensin Enzyme Inhibitors and NSAIDS usage in novel Coronavirus 2019 infection.
  • Review the epidemiological data on COVID-19 in Pediatrics and in the USA up to this point.

There is no educational content to this course. This course is designed to only administer the post-test and collect CME evaluations for the podcast associated with this training.
A Note From Dr. Tarchichi:
This series of podcasts were created to keep the busy physician of today informed and up to date on some of the most important diagnoses and issues we face every day in the care of hospitalized children. Please log in, complete a brief quiz, a course evaluation and get your CME credit. Thank you for listening and enjoy.

Suggested Additional Reading:

  1. Hydroxychloroquine and azithromycin as a treatment of COVID-19:results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents. March 20, 2020. Journal Pre-proof. Correspondence.
  2. Lei Fang et al. Are patients with HTN and Diabetes at risk for COVID-19 infection? Lancet, March 11, 2020.
  3. Guan et al. Clinical Characteristics of Coronavirus disease 2019 in China. NEJM Feb 28, 2020.
  4. Dong et al. Epidemiological characteristics of 2143 Peds patients with 2019 Coronavirus Disease in China. Pediatrics. March 2020.
  5. MMWR - Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020.
  6. Van Doremalen et al. Aerosol and Surface Stability of SARS-CoV-2 as compared with SARS-CoV-1. NEJM March 17, 2020. Correspondence.
  7. Vincent Chang et al. Escalating infection control response to the rapidly evolving epidemiology of the Coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Infection Control and Hospital Epidemiology. March 2020.
  8. Ganyani Tapiwa et al. Estimating the generation interval for COVID 19 based on symptom-onset data. MedRix – not yet peer reviewed.
  9. Nishiura et al. Serial interval of novel Coronavirus (COVID-19) infections. International Journal of Infectious Diseases, Feb 27, 2020.

Megan Culler Freeman, MD, PhD — Coyne Lab, Pediatric Infectious Diseases Fellow
CHP Pediatric Scientist Development Program, UPMC Children’s Hospital of Pittsburgh
No relationships with industry relevant to the content of this educational activity have been disclosed.
Tony R. Tarchichi, MD — Assistant Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C. Gaffney Diagnostic Referral Group
No relationships with industry relevant to the content of this educational activity have been disclosed.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity is approved for AMA PRA Category 1 Credit™

The University of Pittsburgh is an affirmative action, equal opportunity institution.